Diversity of cultivable β -glycosidase-producing micro-organisms isolated from the soil of a ginseng field and their ginsenosides-hydrolysing activity
Authors:
Open Access
- 30 September 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Letters in Applied Microbiology
- Vol. 58 (2) , 138-144
Abstract
This research aimed to explore the diversity of cultivable β‐glycosidase‐producing micro‐organisms in ginseng field soil. Fifty‐three strains showing β‐glucosidase activity were isolated from a ginseng field, using a newly designed Esculin‐R2A agar. All the isolated strains belonged to the genus Agrobacterium, Arthrobacter, Burkholderia, Dyella, Edaphobacter, Luteibacter, Mucilaginibacter, Paenibacillus, Phenylobacterium, Pseudomonas, Sphingomonas and Streptomyces. The main β‐glucosidase‐producing micro‐organisms in the ginseng field soil were Sphingomonas, Burkholderia, Luteibacter and Streptomyces, while concentrations of Agrobacterium, Arthrobacter, Paenibacillus and Pseudomonas were relatively low. Of these micro‐organisms, the strain GS 09 could hydrolyse major ginsenosides Rb1, Rb2 and Rc to the active metabolite compound K. The strain GS 09 belonged to the genus Sphingomonas, and its 16S rRNA gene sequence showed 100% similarities with that of Sphingomonas asaccharolytica. Significance and Impact of the Study This is the first study to provide information of cultivable β‐glycosidase‐producing micro‐organisms in ginseng field soil. The strain GS 09 has potential to be applied on the preparation for minor ginsenoside C‐K in pharmaceutical industry.Keywords
Funding Information
- Ministry of Education of China (20112201110001)
- National Natural Science Foundation of China (20862017)
This publication has 16 references indexed in Scilit:
- Anti-cancer effects of ginsenoside compound k on pediatric acute myeloid leukemia cellsCancer Cell International, 2013
- Ginsenoside metabolite compound K differentially antagonizing tumor necrosis factor-α-induced monocyte–endothelial traffickingChemico-Biological Interactions, 2011
- Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation—The key step of inflammationBiochemical Pharmacology, 2011
- Current Evaluation of the Millennium Phytomedicine- Ginseng (I): Etymology, Pharmacognosy, Phytochemistry, Market and RegulationsCurrent Medicinal Chemistry, 2009
- Ginsenosides compound K and Rh2 inhibit tumor necrosis factor-α-induced activation of the NF-κB and JNK pathways in human astroglial cellsNeuroscience Letters, 2007
- Transformation of Ginsenosides Rb1 and Re from Panax ginseng by Food MicroorganismsBiotechnology Letters, 2005
- Transformation of ginseng saponins to ginsenoside rh2 by acids and human intestinal bacteria and biological activities of their transformantsArchives of Pharmacal Research, 2004
- Microbial transformation of ginsenoside Rb1 by Rhizopus stolonifer and Curvularia lunataBiotechnology Letters, 2003
- Antimetastatic Efficacy of Orally Administered Ginsenoside Rb1in Dependence on Intestinal Bacterial Hydrolyzing Potential and Significance of Treatment with an Active Bacterial MetabolitePlanta Medica, 1998
- Main Ginseng Saponin Metabolites Formed by Intestinal BacteriaPlanta Medica, 1996